title: The exonuclease activity of hPMC2 is required for transcriptional regulation of the QR gene and repair of estrogen-induced abasic sites.
abstract: We have previously reported that the expression of antioxidative stress enzymes is upregulated by trans-hydroxytamoxifen (TOT) in breast epithelial cell lines providing protection against estrogen-induced DNA damage. This regulation involves Estrogen Receptor β (ERβ) recruitment to the Electrophile Response Element (EpRE) and a novel protein, human homolog of Xenopus gene which Prevents Mitotic Catastrophe (hPMC2). We have also demonstrated that ERβ and hPMC2 are required for TOT-dependent recruitment of poly (ADP-ribose) polymerase 1 (PARP-1) and Topoisomerase IIβ (Topo IIβ) to the EpRE. Sequence analysis reveals that the C-terminus of hPMC2 encodes a putative exonuclease domain. Using in vitro kinetic assays, we found that hPMC2 is a 3'-5' non-processive exonuclease that degrades both single-stranded and double-stranded substrates. Mutation of two conserved carboxylate residues drastically reduced the exonuclease activity of hPMC2, indicating the relative importance of the catalytic residues. Western blot analysis of breast cancer cell lines for Quinone Reductase (QR) levels revealed that the intrinsic exonuclease activity of hPMC2 was required for TOT-induced QR upregulation. Chromatin immunoprecipitation (ChIP) assays also indicated that hPMC2 was involved in the formation of strand breaks observed with TOT treatment and is specific for the EpRE-containing region of the QR gene. We also determined that the transcription factor NF-E2-related factor-2 (Nrf2) is involved in the specificity of hPMC2 for the EpRE. In addition, we determined that the catalytic activity of hPMC2 is required for repair of abasic sites that result from estrogen-induced DNA damage. Thus, our study provides a mechanistic basis for transcriptional regulation by hPMC2 and provides novel insights into its role in cancer prevention.
authors: Department of Pharmacology, Case Western Reserve University, Cleveland, OH 44106, USA.
authors: N
authors: N
authors: Krishnamurthy
authors: C R
authors: CR
authors: Ngam
authors: A J
authors: AJ
authors: Berdis
authors: M M
authors: MM
authors: Montano
references: J Biol Chem. 1995 Jul 7;270(27):16002-7
references: 7608159
references: Oncogene. 2004 Apr 1;23(14):2442-53
references: 14676828
references: J Natl Cancer Inst. 1998 Sep 16;90(18):1371-88
references: 9747868
references: Cell Mol Life Sci. 2004 Feb;61(3):336-54
references: 14770297
references: Nucleic Acids Res. 2008 Aug;36(13):4327-36
references: 18586825
references: N Engl J Med. 2006 Jan 19;354(3):270-82
references: 16421368
references: Science. 2006 Jun 23;312(5781):1798-802
references: 16794079
references: Free Radic Biol Med. 2007 Nov 1;43(9):1289-98
references: 17893042
references: J Biol Chem. 1993 Nov 25;268(33):24607-13
references: 7693703
references: Nucleic Acids Res. 1997 Dec 15;25(24):5110-8
references: 9396823
references: Endocr Rev. 2000 Feb;21(1):40-54
references: 10696569
references: Br J Cancer. 2004 Mar;90 Suppl 1:S2-6
references: 15094757
references: Oncogene. 2008 Oct 23;27(49):6376-84
references: 18663360
references: Nature. 2000 Jan 27;403(6768):451-6
references: 10667800
references: J Natl Cancer Inst. 1998 Jul 1;90(13):967-71
references: 9665143
references: Cancer Chemother Pharmacol. 2005 Nov;56 Suppl 1:21-6
references: 16273360
references: Biochemistry. 2001 Jun 19;40(24):7174-9
references: 11401564
references: Oncogene. 1998 Jul 23;17(3):261-70
references: 9690508
references: EMBO J. 1992 Sep;11(9):3323-35
references: 1380454
references: Oncogene. 2007 May 24;26(24):3587-90
references: 17160017
references: Biochem J. 2003 Sep 1;374(Pt 2):337-48
references: 12816537
references: Stroke. 2008 Feb;39(2):463-9
references: 18096835
references: J Biol Chem. 2000 Nov 3;275(44):34306-13
references: 10908561
references: Chem Res Toxicol. 2008 Jan;21(1):93-101
references: 18052105
references: Clin Cancer Res. 2004 Nov 15;10(22):7490-9
references: 15569979
references: Biochemistry. 2001 Jun 19;40(24):7180-91
references: 11401565
references: Mol Endocrinol. 2003 Jul;17(7):1344-55
references: 12714703
references: J Clin Pathol. 2004 May;57(5):523-8
references: 15113861
references: EMBO J. 1999 Jul 1;18(13):3868-75
references: 10393201
references: Oncogene. 2000 Jul 6;19(29):3321-9
references: 10918588
references: Biochim Biophys Acta. 2006 Aug;1766(1):63-78
references: 16675129
references: Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2581-6
references: 9122238
references: J Biol Chem. 1998 Sep 25;273(39):25443-9
references: 9738013